Skip to content

Combine canaloplasty with trabeculectomy for primary angle-closure glaucoma

Combine canaloplasty with trabeculectomy for primary angle-closure glaucoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-15007402
Enrollment
Unknown
Registered
2015-11-16
Start date
2015-11-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

primary angle-closure glaucoma:Combine canaloplasty with trabeculectomy

Sponsors

Ophthalmology and Optometry Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients were 18 years or older at the time of enrollment, able to understand and provide informed consent,and scheduled for glaucoma surgery; 2. A glaucoma diagnosis of primary angle-closure glaucoma (PACG); 3. With glaucomatous optic nerve damage and visual field defects, optic nerve, and (or) perimetry in line with angle-closure glaucoma diagnosis (C / D> 0.6, C / D difference in both eyes> 0.2); 4. With the maximum medicament, elevated intraocular pressure may still cause further damage to the optic nerve, or intolerance, poor compliance if they had historically recorded maximum IOP of 21 mm Hg or greater; 5. Narrow angle or angle closure (<=Shaffer II); 6. No other histories of fundus disease and eye surgery.

Exclusion criteria

Exclusion criteria: 1. Juvenile glaucoma, traumatic glaucoma, neovascular glaucoma, normal tension glaucoma, secondary glaucoma; 2. Severe heart, lung disease, and advanced cancer; 3. With a history of mental illness; 4. Patients receiving anticoagulant therapy, kidney dialysis and pregnant women; 5. Refused to sign the informed consent; 6. Those who can not adhere to the follow-up.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;bleb;

Secondary

MeasureTime frame
anti-glaucoma medicine;

Countries

China

Contacts

Public ContactYuanbo Liang
yuanboliang@126.com+86 18257748686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026